Immuneering Corporation (IMRX:NASDAQ) closed at $3.66 on October 19, 2026, up 1.95% on the day. The stock trades 56.8% below its 52-week high of $8.48 and 8.3% above its 52-week low of $3.38. Over the past year, it lost 35.7%. Immuneering Corporation is part of the Finance sector.
In 252 trading sessions since October 17, 2025, IMRX closed higher on 125 days (50%). Its best day was January 7, 2026 (+23.96%) and its worst was January 8, 2026 (-43.22%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.
Immuneering Corpbiopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to leading pharmaceutical and biotechnology companies.
Find more stocks like IMRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.